Cite
Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis.
MLA
Li, Zhiqiang, et al. “Mutational and Transcriptional Alterations and Clinicopathological Factors Predict the Prognosis of Stage I Hepatocellular Carcinoma : Prediction of Stage I HCC Prognosis.” BMC Gastroenterology, vol. 22, no. 1, Sept. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12876-022-02496-3.
APA
Li, Z., Gao, H., Zhang, X., Liu, Q., & Chen, G. (2022). Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis. BMC Gastroenterology, 22(1), 1–13. https://doi.org/10.1186/s12876-022-02496-3
Chicago
Li, Zhiqiang, Hongqiang Gao, Xiang Zhang, Qiyu Liu, and Gang Chen. 2022. “Mutational and Transcriptional Alterations and Clinicopathological Factors Predict the Prognosis of Stage I Hepatocellular Carcinoma : Prediction of Stage I HCC Prognosis.” BMC Gastroenterology 22 (1): 1–13. doi:10.1186/s12876-022-02496-3.